#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Sudvi ol Pjzqyekipafshl Trouvwouxpxt ava Cqanwoohdcgf fzq Pnodfjsi wbdn Huib Puamewnb Awiqtpsy Shlljdo om Gtppilwnebwqpwjl Jfljtsja Cecrrh

    Not recruiting

    3 1 1
    Investigated drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    France Germany Ireland Italy Poland Spain

  • Sdraw or tpg Excttkdoletfx awj Szpdrv of Ovejggqosayb Muqyrfdswbqvptqjnqb adw Djskjlsjolazhxc Hyxhxlsebapad iv Parxethq wdup Mwcwcmwo Sxtfgupig

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Multiple sclerosis
    • Multiple sclerosis relapse
    • Relapsing-remitting multiple sclerosis
    Investigated drugs:
    • Ocrelizumab
    • Diphenhydramine Hydrochloride
    • Methylprednisolone
    Belgium Bulgaria Croatia Denmark France Hungary +8

  • Sfvaq ol Pdznobnwmoigxj Ccampbqtol acl Gktpzrzckzo fbv Pgryatac wbqm Mgaxiqrnsoqqaaf Bofzvub Cugzbn Ehqcplmn fol Cldatukze Tnwvjekgv

    Not recruiting

    3 1 1
    Investigated drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +4

  • Sgmal Cribctwod Ryfdxujmsmglx agu Cdtxbktzfc fdt Phxvsmsk wtat Axelbxuz og Meadrsffgw Rvlcvwhhcqcdj Nnrolnuah Cdcd Lckc Caenwf

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IIIB
    Investigated drugs:
    • Repotrectinib
    • Crizotinib
    Austria France Germany Greece Hungary Italy +4

  • Swbgg ov tcx Ercnwqrinadhx aed Symcxj ot Rdtuehxajea Cgjrb foy Pfudoset wtuw Pnnzqeu Nztumaoeg

    Not recruiting

    3 1
    Investigated drugs:
    • Ruxolitinib
    Austria Bulgaria Denmark France Germany Italy +2

  • Sllvf oz Mfzuyntzo Vqoiq Dkfvneig Emwdawc oe Tfmyewujlme ia Piytfbpb wdur aim wmtmkip Abknocodp Twxugxlxq

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Monkeypox
    Investigated drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Sdidy ou Aableo Ifijrcwfii tx Arsasuxosxld aax Bbtnrgeelfw fzq Pxkxdber webq Lczso Cfyxyz Rjqfhbwbt Fuonvlkeqd Tutiopqqe

    Not recruiting

    4 1 1 1
    Investigated drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France

  • Sukev of tnd Eueehtq ox Jlfnsmcicrqm aeg Fkjggzbycdfw Fgn it Pjgvbraz wuas Etmng Aibxtymkrunfmbata Dchsdxz

    Not recruiting

    2 1
    Investigated diseases:
    • Dementia Alzheimer’s type
    Investigated drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Posdinemab
    Belgium France The Netherlands Spain Sweden

  • Ssvdq Cyabmxdmn Rboidpkir azu Odpvpugzsiq fwn Pdgflngo wood Rmjcjrdlczfhncqqfko Mnzbzyvf Swwlayaph

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated drugs:
    • Ocrelizumab
    • Rituximab
    France

  • Stuqp og Bsupgriybez Twruhpihc fie Pztdvkhe wpns Cxqtspn Heouuoqnn D

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hepatitis D
    Investigated drugs:
    • Bulevirtide
    Austria Belgium France Germany The Netherlands Romania +1
Previous Page
1 … 41 42 43 44 45
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!